DNA methylation and allelic losses on chromosome arm 14q in oligodendroglial tumours

Neuropathology and Applied Neurobiology

Volumn 32, Issue 5, 2006, Pages 517-524

  Felsberg, J ^a,b   Yan, P S ^c   Huang, T H M ^c   Milde, U ^a   Schramm, J ^a   Wiestler, O D ^d   Reifenberger, G ^b   Pietsch, T ^a   Waha, A ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c OHIO STATE UNIVERSITY   (United States)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Chromosome 14; DNA methylation; Loss of heterozygosity; Oligodendroglioma; Tumour suppressor gene

Indexed keywords

DNA FRAGMENT; MICROSATELLITE DNA;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CHILD; CHROMOSOME 14Q; CLINICAL ARTICLE; DNA DETERMINATION; DNA HYBRIDIZATION; DNA METHYLATION; FEMALE; GENE CONTROL; GENE DELETION; GENE LOCUS; GENOME; GLIOMA; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; ALLELES; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 14; DNA METHYLATION; DNA, NEOPLASM; FEMALE; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; OLIGODENDROGLIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SULFITES;

EID: 33748749606     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2006.00759.x     Document Type: Article

References (40)

1. Reifenberger G, Kros JM, Burger KJ, Louis DN, Collins VP. Oligodendroglial tumours. In Pathology and Genetics of Tumours of the Nervous System. World Health Organization Classification of Tumours, 2nd edn. Eds P Kleihues, WK Cavenee. Lyon: IARC, 2000; 55-70
2. Ichimura K, Ohgaki H, Kleihues P, Collins VP. Molecular pathogenesis of astrocytic tumours. J Neurooncol 2004; 70: 137-60
3. Jeuken JW, von Deimling A, Wesseling P. Molecular pathogenesis of oligodendroglial tumors. J Neurooncol 2004; 70: 161-81
4. Ino Y, Betensky RA, Zlatescu MC, Sasaki H, Macdonald DR, Stemmer-Rachamimov AO, Ramsay DA, Cairncross JG, Louis DN. Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin Cancer Res 2001; 7: 839-45
5. Felsberg J, Erkwoh A, Sabel M, Kirsch L, Blaschke B, Schlegel U, Schramm J, Wiestler OD, Reifenberger G. Allelic losses on 1p and 19q in oligodendroglial tumors: refinement of candidate tumor suppressor gene regions on 1p and correlation with survival data. Brain Pathol 2004; 14: 121-30
6. Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 2000; 18: 636-45
7. Hoang-Xuan K, He J, Huguet S, Mokhtari K, Marie Y, Kujas M, Leuraud P, Capelle L, Delattre JY, Poirier J, Broet P, Sanson M. Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression. Neurology 2001; 57: 1278-81
8. Chahlavi A, Kanner A, Peereboom D, Staugaitis SM, Elson P, Barnett G. Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results. J Neurooncol 2003; 61: 267-73
9. Hashimoto N, Murakami M, Takahashi Y, Fujimoto M, Inazawa J, Mineura K. Correlation between genetic alteration and long-term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p. Cancer 2003; 97: 2254-61
10. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 1994; 145: 1175-90
11. Zhu JJ, Santarius T, Wu X, Tsong J, Guha A, Wu JK, Hudson TJ, Black PM. Screening for loss of heterozygosity and microsatellite instability in oligodendrogliomas. Genes Chromosomes Cancer 1998; 21: 207-16
12. Kros JM, van Run PR, Alers JC, Beverloo HB, van den Bent MJ, Avezaat CJ, van Dekken H. Genetic aberrations in oligodendroglial tumours: an analysis using comparative genomic hybridization (CGH). J Pathol 1999; 188: 282-8
13. Dichamp C, Taillibert S, Aguirre-Cruz L, Lejeune J, Marie Y, Kujas M, Delattre JY, Hoang-Xuan K, Sanson M. Loss of 14q chromosome in oligodendroglial and astrocytic tumors. J Neurooncol 2004; 67: 281-5
14. Hu J, Pang JC, Tong CY, Lau B, Yin XL, Poon WS, Jiang CC, Zhou LF, Ng HK. High-resolution genome-wide allelotype analysis identifies loss of chromosome 14q as a recurrent genetic alteration in astrocytic tumours. Br J Cancer 2002; 87: 218-24
15. Waha A, Rodrigues FJ, Waha A, Meyer Puttlitz B, Cavenee WK, Wiestler OD, Huang TH, Yan PS. Methylation profiling identifies epigenetic markers for high-grade gliomas. Cancer Genomics Proteomics 2004; 1: 209-14
16. Yan PS, Wei SH, Huang TH. Differential methylation hybridization using CpG island arrays. Methods Mol Biol 2002; 200: 87-100
17. Kleihues P, Cavenee WK. Oligodendroglial tumours and mixed gliomas. In Pathology and Genetics of Tumours of the Nervous System. World Health Organization Classification of Tumours, 2nd edn. Eds P Kleihues, WK Cavenee. Lyon: IARC, 2000; 55-70
18. Bostrom J, Muhlbauer A, Reifenberger G. Deletion mapping of the short arm of chromosome 1 identifies a common region of deletion distal to D1S496 in human meningiomas. Acta Neuropathol (Berl) 1997; 94: 479-85
19. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-6
20. Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC, Schuller DEYuL, Bloomfield CD, Caligiuri MA, Yates A, Nishikawa R, Su Huang H, Petrelli NJ, Zhang X, O'Dorisio MS, Held WA, Cavenee WK, Plass C. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 2000; 24: 132-8
21. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001; 61: 3225-9
22. Debiec-Rychter M, Alwasiak J, Liberski PP, Nedoszytko B, Babinska M, Mrozek K, Imielinski B, Borowska-Lehman J, Limon J. Accumulation of chromosomal changes in human glioma progression. A cytogenetic study of 50 cases. Cancer Genet Cytogenet 1995; 85: 61-7
23. Bigner SH, Matthews MR, Rasheed BK, Wiltshire RN, Friedman HS, Friedman AH, Stenzel TT, Dawes DM, McLendon RE, Bigner DD. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization. Am J Pathol 1999; 155: 375-86
24. Deng Y, Yao L, Chau L, Ng SS, Peng Y, Liu X, Au WS, Wang J, Li F, Ji S, Han H, Nie X, Li Q, Kung HF, Leung SY, Lin MC. N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation. Int J Cancer 2003; 106: 342-7
25. Takai D, Jones PA. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci USA 2002; 99: 3740-5
26. Hong C, Bollen AW, Costello JF. The contribution of genetic and epigenetic mechanisms to gene silencing in oligodendrogliomas. Cancer Res 2003; 63: 7600-5
27. Mollemann M, Wolter M, Felsberg J, Collins VP, Reifenberger G. Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors. Int J Cancer 2005; 113: 379-85
28. Alonso ME, Bello MJ, Gonzalez-Gomez P, Arjona D, Lomas J, de Campos JM, Isla A, Sarasa JL, Rey JA. Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas. Cancer Genet Cytogenet 2003; 144: 134-42
29. Dong S, Pang JC, Hu J, Zhou LF, Ng HK. Transcriptional inactivation of TP73 expression in oligodendroglial tumors. Int J Cancer 2002; 98: 370-5
30. Dong SM, Pang JC, Poon WS, Hu J, To KF, Chang AR, Ng HK. Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors. J Neuropathol Exp Neurol 2001; 60: 808-16
31. Thompson PM, Seifried BA, Kyemba SK, Jensen SJ, Guo C, Maris JM, Brodeur GM, Stram DO, Seeger RC, Gerbing R, Matthay KK, Matise TC, White PS. Loss of heterozygosity for chromosome 14q in neuroblastoma. Med Pediatr Oncol 2001; 36: 28-31
32. Lee DJ, Koch WM, Yoo G, Lango M, Reed A, Califano J, Brennan JA, Westra WH, Zahurak M, Sidransky D. Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinoma. Clin Cancer Res 1997; 3: 501-5
33. Thorstensen L, Qvist H, Nesland JM, Giercksky KE, Lothe RA. Identification of two potential suppressor gene regions on chromosome arm 14q that are commonly lost in advanced colorectal carcinomas. Scand J Gastroenterol 2001; 36: 1327-31
34. Herbers J, Schullerus D, Muller H, Kenck C, Chudek J, Weimer J, Bugert P, Kovacs G. Significance of chromosome arm 14q loss in nonpapillary renal cell carcinomas. Genes Chromosomes Cancer 1997; 19: 29-35
35. Beroud C, Fournet JC, Jeanpierre C, Droz D, Bouvier R, Froger D, Chretien Y, Marechal JM, Weissenbach J, Junien C. Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas. Genes Chromosomes Cancer 1996; 17: 215-24
36. Wu SQ, Hafez GR, Xing W, Newton M, Chen XR, Messing E. The correlation between the loss of chromosome 14q with histologic tumor grade, pathologic stage, and outcome of patients with nonpapillary renal cell carcinoma. Cancer 1996; 77: 1154-60
37. Schullerus D, Herbers J, Chudek J, Kanamaru H, Kovacs G. Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas. J Pathol 1997; 183: 151-5
38. Kamnasaran D, Cox DW. Current status of human chromosome 14. J Med Genet 2002; 39: 81-90
39. Weber RG, Bostrom J, Wolter M, Baudis M, Collins VP, Reifenberger G, Lichter P. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 1997; 94: 14719-24
40. Cai DX, Banerjee R, Scheithauer BW, Lohse CM, Kleinschmidt-Demasters BK, Perry A. Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications. J Neuropathol Exp Neurol 2001; 60: 628-36